Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
text
Tags
biotech
startups
boston
boston blog main
boston top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
antisense oligonucleotide
artificial intelligence
azacitidine
benzodiazepines
beta-thalassemia
biogen
blackstone group
blackstone life sciences
clinical trials
columbia university
dacogen
david goldstein
deals
decitabine
depression
dna
epi4k
epigenetics
epilepsy
epizyme
essential tremor
farydak
flagship pioneering
fulcrum therapeutics
health
insulated genomic domains
investing
kaleido biosciences
kiran reddy
machine learning
What
drugs
3
×
medicines
3
×
new
3
×
research
3
×
aims
biotech
called
developing
algorithms
approach
backed
based
batch
bottlenecks
cause
ceo
clinical
combinator’s
cost
debuts
development
dollars
drug
epigenetic
epigenetics
epilepsy
field
fix
flagship’s
genes
genetic
labs
latest
learning
links
machine
marcio
millions
morning
mutations
Language
unset
Current search:
drugs
×
medicines
×
research
×
new
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@techcrunch.com
6 years ago
Reverie Labs uses new machine learning algorithms to fix drug development bottlenecks
